Patent ID: 11905338
Assignee: UNIVERSITÉ DE MONTPELLIER
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 9:
10. The peptide according to claim 1, wherein the peptide further comprises covalently linked to the C-terminal end of said amino acid sequence, one or more entities selected from a L-amino acid, a D-amino acid, a non-natural amino acid, a cysteamide, a thiol, an amide, a carboxyl, a linear C1-C6 alkyl that is optionally substituted, a ramified C1-C6 alkyl that is optionally substituted, a primary amine, a secondary amine, an osidic derivative, a lipid, a phospholipid, a fatty acid, a cholesterol, a poly-ethylene glycol, a nuclear localization signal, and/or a targeting molecule; and/or wherein the peptide further comprises covalently linked to the N-terminal end of said amino acid sequence, one or more chemical entities selected from a L-amino acid, a D-amino acid, a non-natural amino acid, an amine, an acetyl, a linear C1-C6 alkyl that is optionally substituted, a ramified C1-C6 alkyl that is optionally substituted, a primary amine, a secondary amine, an osidic derivative, a lipid, a phospholipid, a fatty acid, a cholesterol, a poly-ethylene glycol, a nuclear localization signal, and/or a targeting molecule.